Mutation testing - PDFSEARCH.IO - Document Search Engine

Mutation testing
Results: 207

#	Item
61	MSAC Application 1380 Germline BRCA mutation testing to determine eligibility for olaparib maintenance therapy in women with platinum-sensitive relapsed ovarian cancer (including fallopian tube or primary peritoneal canc Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-12-15 23:44:34 Olaparib Primary peritoneal carcinoma Ovarian cancer BRCA mutation Fallopian tube cancer PARP1 Serous carcinoma PARP inhibitor Breast cancer Medicine Oncology Gynaecological cancer
62	Microsoft Word[removed]Final PSD - RAS testing for cetuximab-accessible.DOCX Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-12-16 20:01:28 Cetuximab KRAS Panitumumab Gastrointestinal cancer Ras subfamily Colorectal cancer HRAS Biomarker Mutation Medicine Biology Bristol-Myers Squibb
63	Public Summary Document Application No.1207 – BRAF V600 mutation testing associated with access to PBS-listed dabrafenib Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:50:11 Melanoma Organochlorides Sulfonamides Vemurafenib BRAF Protein kinase inhibitor Pharmaceutical Benefits Scheme Metastasis Melbourne Sports and Aquatic Centre Medicine Healthcare in Australia Health
64	Consultation DAP to guide the assessment of BRAF V600 testing in unresectable stage IIC or metastatic stage IV cutaneous melanoma Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:33 Vemurafenib Mutation testing Cancer Metastasis Protein kinase inhibitor Immunotherapy Medicine Melanoma BRAF
65	Public Summary Document Application 1363 – RAS (KRAS and NRAS) mutation testing for eligibility to access panitumumab Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-12-03 00:24:10 Cetuximab KRAS Panitumumab Oncogenes Gastrointestinal cancer Ras subfamily Colorectal cancer HRAS Biomarker Medicine Biology Bristol-Myers Squibb
66	Microsoft Word[removed]ContractedAssessmentReport accessibility-Partial.docx Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:36 Multiple endocrine neoplasia type 2 Genetic testing Mutation Pheochromocytoma Hyperparathyroidism Cancer Medullary thyroid cancer Medicine Health Endocrine system
67	1216 Consultation Protocol to guide the assessment of testing for hereditary mutations in the Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-19 23:54:21 Medical genetics Pancreas disorders Pediatrics Mutation Cystic fibrosis Congenital absence of the vas deferens Point mutation Sweat test CFTR Biology Health Medicine
68	OUTCOMES RESEARCH IN REVIEW Early Genetic Counseling and Testing for Breast Cancer Patients and Impact on Surgical Decision Schwartz MD, Lerman C, Brogan B, et al. Impact of BRCA1/BRCA2 counseling and testing on newly d Add to Reading List Source URL: www.turner-white.com Language: English Ribbon symbolism Tumor markers Tumor suppressor genes BRCA mutation Mutation Mastectomy Ovarian cancer BRCA1 Oophorectomy Medicine Oncology Breast cancer
69	Microsoft Word - ic_CNGB3 and CNGA3_Achromatopsia.doc Add to Reading List Source URL: www.genedx.com Language: English - Date: 2012-12-22 10:21:30 Genetics Applied genetics Channelopathy Achromatopsia DNA Genetic testing Prenatal diagnosis DNA profiling Mutation Biology Medical genetics Medicine
70	Microsoft Word - new approach final one.doc Add to Reading List Source URL: dspace.nitrkl.ac.in Language: English - Date: 2013-12-17 06:37:18 Computer security Mutation testing Access control Policy Authorization Security XACML Software testing

UPDATE